These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2677804)

  • 1. [Phase IV of treatment evaluation].
    Linden M
    Nervenarzt; 1989 Aug; 60(8):453-61. PubMed ID: 2677804
    [No Abstract]   [Full Text] [Related]  

  • 2. The consequences of drug misuse on post-marketing surveillance.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):867-71. PubMed ID: 27095119
    [No Abstract]   [Full Text] [Related]  

  • 3. [Post-marketing surveillance systems for psychoactive prescription drug abuse].
    Nordmann S; Frauger E; Pauly V; Rouby F; Mallaret M; Micallef J; Thirion X
    Therapie; 2011; 66(3):263-72. PubMed ID: 21819810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Theoretical assessment and personal experience with the combination of psychotropic drugs and psychotherapy].
    Seidler C
    Z Arztl Fortbild (Jena); 1981 May; 75(9):412-5. PubMed ID: 7197087
    [No Abstract]   [Full Text] [Related]  

  • 5. A patient-initiated postmarketing surveillance system.
    Fisher S; Bryant SG; Solovitz BL; Kluge RM
    Psychopharmacol Bull; 1987; 23(3):400-4. PubMed ID: 3432511
    [No Abstract]   [Full Text] [Related]  

  • 6. Placebo-psychotherapy combinations: inappropriate representations of psychotherapy in drug-psychotherapy comparative trials.
    Hollon SD; DeRubeis RJ
    Psychol Bull; 1981 Nov; 90(3):467-77. PubMed ID: 7029596
    [No Abstract]   [Full Text] [Related]  

  • 7. [Postmarketing surveillance of drugs].
    Simon P; Soubrié C
    Rev Prat; 1983 Jan; 33(1-2):23-8. PubMed ID: 6823538
    [No Abstract]   [Full Text] [Related]  

  • 8. Combining drugs and electroconvulsive therapy: safe and/or effective?
    Fink M
    J Clin Psychopharmacol; 1993 Apr; 13(2):85-6. PubMed ID: 8463452
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
    Glasser SP; Salas M; Delzell E
    J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in adverse drug reactions in phase III and phase IV of the drug evaluation process.
    Linden M
    Psychopharmacol Bull; 1993; 29(1):51-6. PubMed ID: 8378512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotherapy and pharmacotherapy.
    Gonzalez de Rivera JL
    J Am Acad Psychoanal Dyn Psychiatry; 2007; 35(2):173-7. PubMed ID: 17650970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologico-psychotherapeutic treatment of borderline syndrome. A case report].
    Schüssler G; Kropf D
    Psychother Psychosom Med Psychol; 1983 Jul; 33(4):136-41. PubMed ID: 6611806
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of patients with substance use disorders, second edition. American Psychiatic Association.
    ; Kleber HD; Weiss RD; Anton RF; Rounsaville BJ; George TP; Strain EC; Greenfield SF; Ziedonis DM; Kosten TR; Hennessy G; O'Brien CP; Connery HS; ; McIntyre JS; Charles SC; Anzia DJ; Nininger JE; Cook IA; Summergrad P; Finnerty MT; Woods SM; Johnson BR; Yager J; Pyles R; Lurie L; Cross CD; Walker RD; Peele R; Barnovitz MA; Gray SH; Shemo JP; Saxena S; Tonnu T; Kunkle R; Albert AB; Fochtmann LJ; Hart C; Regier D
    Am J Psychiatry; 2006 Aug; 163(8 Suppl):5-82. PubMed ID: 16981488
    [No Abstract]   [Full Text] [Related]  

  • 14. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychotherapy research].
    Ottosson JO
    Lakartidningen; 1976 Mar; 73(13):1203-6. PubMed ID: 772334
    [No Abstract]   [Full Text] [Related]  

  • 16. Counselling: indications and results.
    Cramer D
    Br J Hosp Med; 1993 Sep 15-Oct 5; 50(6):333-6. PubMed ID: 8242217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of several psychotherapeutic methods including psychopharmaceuticals. A case of obsessive-compulsive disorder].
    Irgens A
    Tidsskr Nor Laegeforen; 1997 Apr; 117(9):1314-5. PubMed ID: 9182364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders.
    Wagner AW; Bystritsky A; Russo JE; Craske MG; Sherbourne CD; Stein MB; Roy-Byrne PP
    Depress Anxiety; 2005; 21(3):99-105. PubMed ID: 15965996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive therapy in the treatment of psychotic and postpsychotic states--an overview].
    Perris C
    Lakartidningen; 1986 Apr; 83(16):1488-91. PubMed ID: 3517532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Critical study of methods of postmarketing drug surveillance].
    Gut JP; Auriche M; Spriet-Pourra C; Juillet Y
    Therapie; 1985; 40(5):313-9. PubMed ID: 3913048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.